Saphenous Vein as Y-composite Versus Aortocoronary Conduit for CABG (CONFIG2)
Coronary Artery Disease
About this trial
This is an interventional treatment trial for Coronary Artery Disease focused on measuring coronary artery bypass grafting, saphenous vein, coronary angiography
Eligibility Criteria
Inclusion Criteria: A patient who is going to receive coronary artery bypass grafting Older than 19 years Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft Exclusion Criteria: Other concomitant procedures (e.g. valve or aorta surgery) is planned Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer) Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft Patients whose ascending aorta is not suitable to aortocoronary anastomosis (e.g. ascending aorta aneurysm, porcelain aorta) Emergency operation Patients who have connective tissue disease Reoperative coronary artery bypass grafting
Sites / Locations
- Seoul National University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Y-composite grafting
Aortocoronary grafting
The saphenous vein is anastomosed to the middle portion of the left internal thoracic artery as Y-composite fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.
The saphenous vein is anastomosed to the ascending aorta as aortocoronary fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.